General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsPfizer had clues its blockbuster drug could prevent Alzheimer's. Why didn't it tell the world?
A team of researchers inside Pfizer made a startling find in 2015: The companys blockbuster rheumatoid arthritis therapy Enbrel, a powerful anti-inflammatory drug, appeared to reduce the risk of Alzheimers disease by 64 percent.
The results were from an analysis of hundreds of thousands of insurance claims. Verifying that the drug would actually have that effect in people would require a costly clinical trial and after several years of internal discussion, Pfizer opted against further investigation and chose not to make the data public, the company confirmed.
Researchers in the companys division of inflammation and immunology urged Pfizer to conduct a clinical trial on thousands of patients, which they estimated would cost $80 million, to see if the signal contained in the data was real, according to an internal company document obtained by The Washington Post.
Enbrel could potentially safely prevent, treat and slow progression of Alzheimers disease, said the document, a PowerPoint slide show that was prepared for review by an internal Pfizer committee in February 2018.
The company told The Post that it decided during its three years of internal reviews that Enbrel did not show promise for Alzheimers prevention because the drug does not directly reach brain tissue. It deemed the likelihood of a successful clinical trial to be low. A synopsis of its statistical findings prepared for outside publication, it says, did not meet its rigorous scientific standards.
https://www.msn.com/en-us/health/health-news/pfizer-had-clues-its-blockbuster-drug-could-prevent-alzheimers-why-didnt-it-tell-the-world/ar-AACoIHv?li=BBnb7Kz&ocid=mailsignout
democratisphere
(17,235 posts)Healthcare is an environment of routine price gouging yet it is rarely talked about and zero is done about it. What an out of control mess.
woodsprite
(11,911 posts)And Im sure as many other places he can think of.
democratisphere
(17,235 posts)As you have pointed out, other countries will follow in the destruction. So much of this crap we do to ourselves, while our adversaries sit back and smile.
uponit7771
(90,335 posts)ProfessorPlum
(11,256 posts)CabalPowered
(12,690 posts)NIH provides millions in grants every year. Pfizer would get a grant, it just wouldn't cover the entire expense.
https://www.nih.gov/health-information/nih-clinical-research-trials-you
ProfessorPlum
(11,256 posts)they aren't grants for large clinical trials by publicly traded pharmaceutical companies. Those costs are borne by shareholders and revenues from sales.
NIH supports a ton of academic research, often things that eventually lead to drugs, but they don't do R&D or clinical trials for drug companies. NIH grant programs are super important, though, and should be funded much more than they are.
Farmer-Rick
(10,154 posts)Do you want a peaceful, healthy and equitable society? Or do you want capitalism? The choice has been made.
greymattermom
(5,754 posts)A major part of my scientific career was examining the role of inflammation in the aging brain, and some older work I did is getting cited a lot now. Now that this is known, NIA should fund a trial of generic TNF inhibitors.
mopinko
(70,078 posts)as do bizarro auto-immune problems. my niece is on embrel. 2 of my daughters have plaque psoriasis.
seems like the patent on embrel should be getting close to running out? these biologics have such promise.
and as expensive as they are, when you compare them to the cost of treating people w these diseases, even just the medical costs, they are very cost effective. the human costs? everyone should be able to get these treatments. we need to care for our human capital. period.
Laura PourMeADrink
(42,770 posts)personal theories.
RoadMan
(48 posts)probably can make more money keeping people going back to doctors though.
Dennis Donovan
(18,770 posts)...than with one that could prevent it. It was a business decision.
Laura PourMeADrink
(42,770 posts)drug. The $80 mill cost to have researched this Enbrel possibility is chump change. Simple Google search showing that it's a subject of debate...but could cost a billion + to develop a single drug. Evidently since Enbrel already developed, cost significantly lower.
ProfessorPlum
(11,256 posts)since the population of people who might get and might want to prevent AD is vast compared to the number of people with active AD.
ancianita
(36,023 posts)The goal is steady profit, not a cure that could end their sales down the road.